|
Research Officer
Centenary Institute, Australia
Email: e.stewart@centenary.org.au
VALIDATE Role:
Network Associate
Research Keywords:
TB Subunit Vaccines, Mucosal Vaccination, Mucosal Adjuvants
Biography:
I completed my PhD at the University of Sydney and Centenary Institute in 2023, which was focused on understanding the immune mechanisms responsible for the effectiveness of mucosal subunit vaccines against Mycobacterium tuberculosis and SARS-CoV-2. Since then, I have worked as a postdoctoral researcher and project manager in the Tuberculosis Research Program, working on the development of a nasal SARS-CoV-2 vaccine and continuing to study the immune responses to inhaled TB subunit vaccines.
Related Websites:
LinkedIn
Twitter
Key Publications:
- Stewart EL et al. Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is a cellular receptor for delta inulin adjuvant. ICB. June 2024. 19/06/2024
- Stewart EL et al. Lung IL-17A-producing CD4+ T cells correlate with protection after intrapulmonary vaccination with differentially adjuvanted tuberculosis vaccines. Vaccines. January 2024.
- Stewart EL, et al. Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2. Mucosal Immunol. June 2022.
- Stewart EL & Ferrell KC, et al. Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction. Mucosal Immunol. February 2021.
|
